ACE Inhibition in Anti-Thy1 Glomerulonephritis Limits Proteinuria but Does Not Improve Renal Function and Structural Remodeling
Background/Aims: ACE inhibitor (ACE-I) treatment effectively inhibits proteinuria and ameliorates the course of various renal diseases. In experimental glomerulonephritis, however, angiotensin II (AngII) infusion has also been shown to be renoprotective. We evaluated the long-term (28 days) course o...
Main Authors: | Peter E. Westerweel, Jaap A. Joles, Krista den Ouden, Roel Goldschmeding, Maarten B. Rookmaaker, Marianne C. Verhaar |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2012-01-01
|
Series: | Nephron Extra |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/335750 |
Similar Items
-
Lycium barbarum polysaccharides attenuate rat anti-Thy-1 glomerulonephritis through mediating pyruvate dehydrogenase
by: Ting Lu, et al.
Published: (2019-08-01) -
ESTIMATION OF NEPHROPROTECTIVE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME RAMIPRIL IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS
by: M.A. Dolinnayä, et al.
Published: (2017-03-01) -
Effect of Huaier On the Proliferation of Mesangial Cells in Anti-Thy-1 Nephritis
by: Jiuxu Bai, et al.
Published: (2017-08-01) -
Primary glomerulonephritis: A review of important recent discoveries
by: Jürgen Floege
Published: (2013-09-01) -
Immune-complex glomerulonephritis with a membranoproliferative pattern in Frasier syndrome: a case report and review of the literature
by: Daisuke Matsuoka, et al.
Published: (2020-08-01)